Nuance of Inward Rectifying Potassium (Kir) Channel Dysfunctions in Neurodegenerative Diseases

Overview

Journal Neural Regen Res

Date 2023 Oct 31

PMID 37905861

Authors

Benjamin Garland

Linlin Ma

Affiliations

Soon will be listed here.

Citing Articles

Potassium and calcium channels in different nerve cells act as therapeutic targets in neurological disorders.

Qiu Q, Yang M, Gong D, Liang H, Chen T Neural Regen Res. 2024; 20(5):1258-1276.

PMID: 38845230 PMC: 11624876. DOI: 10.4103/NRR.NRR-D-23-01766.

References

Liss B, Haeckel O, Wildmann J, Miki T, Seino S, Roeper J . K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons. Nat Neurosci. 2005; 8(12):1742-51. DOI: 10.1038/nn1570. View

Maezawa I, Nguyen H, Di Lucente J, Jenkins D, Singh V, Hilt S . Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept. Brain. 2017; 141(2):596-612. PMC: 5837198. DOI: 10.1093/brain/awx346. View

Du R, Sun H, Hu Z, Lu M, Ding J, Hu G . Kir6.1/K-ATP channel modulates microglia phenotypes: implication in Parkinson's disease. Cell Death Dis. 2018; 9(3):404. PMC: 5852118. DOI: 10.1038/s41419-018-0437-9. View

Peric M, Nikolic L, Andjus P, Bataveljic D . Dysfunction of oligodendrocyte inwardly rectifying potassium channel in a rat model of amyotrophic lateral sclerosis. Eur J Neurosci. 2021; 54(7):6339-6354. DOI: 10.1111/ejn.15451. View

Liu M, Liu C, Xiao X, Han S, Bi M, Jiao Q . Role of upregulation of the K channel subunit SUR1 in dopaminergic neuron degeneration in Parkinson's disease. Aging Cell. 2022; 21(5):e13618. PMC: 9124303. DOI: 10.1111/acel.13618. View

Tong X, Ao Y, Faas G, Nwaobi S, Xu J, Haustein M . Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice. Nat Neurosci. 2014; 17(5):694-703. PMC: 4064471. DOI: 10.1038/nn.3691. View

Chen M, Hu Z, Ding J, Du R, Hu G . Astrocytic Kir6.1 deletion aggravates neurodegeneration in the lipopolysaccharide-induced mouse model of Parkinson's disease via astrocyte-neuron cross talk through complement C3-C3R signaling. Brain Behav Immun. 2021; 95:310-320. DOI: 10.1016/j.bbi.2021.04.003. View

Santiago J, Potashkin J . System-based approaches to decode the molecular links in Parkinson's disease and diabetes. Neurobiol Dis. 2014; 72 Pt A:84-91. DOI: 10.1016/j.nbd.2014.03.019. View

Peng K, Hu J, Xiao J, Dan G, Yang L, Ye F . Mitochondrial ATP-sensitive potassium channel regulates mitochondrial dynamics to participate in neurodegeneration of Parkinson's disease. Biochim Biophys Acta Mol Basis Dis. 2018; 1864(4 Pt A):1086-1103. DOI: 10.1016/j.bbadis.2018.01.013. View

10.

Szeto V, Chen N, Sun H, Feng Z . The role of K channels in cerebral ischemic stroke and diabetes. Acta Pharmacol Sin. 2018; 39(5):683-694. PMC: 5943906. DOI: 10.1038/aps.2018.10. View

11.

Akyuz E, Villa C, Beker M, Elibol B . Unraveling the Role of Inwardly Rectifying Potassium Channels in the Hippocampus of an Aβ-Infused Rat Model of Alzheimer's Disease. Biomedicines. 2020; 8(3). PMC: 7148495. DOI: 10.3390/biomedicines8030058. View

12.

Nguyen H, Grossinger E, Horiuchi M, Davis K, Jin L, Maezawa I . Differential Kv1.3, KCa3.1, and Kir2.1 expression in "classically" and "alternatively" activated microglia. Glia. 2016; 65(1):106-121. PMC: 5113690. DOI: 10.1002/glia.23078. View

13.

Wilcock D, Vitek M, Colton C . Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease. Neuroscience. 2009; 159(3):1055-69. PMC: 2699894. DOI: 10.1016/j.neuroscience.2009.01.023. View